Table of Contents

company-logo

Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. It develops TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic intervention against age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, as well as for post-chemotherapy recovery by interrupting and preventing the interleukin-17 induced inflammatory pathways. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. on October 10, 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Baltimore, Maryland.

Telomir Pharmaceuticals Dividend Announcement

• Telomir Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Telomir Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Telomir Pharmaceuticals Dividend History

Telomir Pharmaceuticals Dividend Yield

Telomir Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Telomir Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Telomir Pharmaceuticals Financial Ratios

P/E ratio-6.92
PEG ratio-0.07
P/B ratio82.73
ROE-734.96%
Payout ratio0.00%
Current ratio3.93
Quick ratio3.93
Cash Ratio3.53

Telomir Pharmaceuticals Dividend FAQ

Does Telomir Pharmaceuticals stock pay dividends?
Telomir Pharmaceuticals does not currently pay dividends to its shareholders.
Has Telomir Pharmaceuticals ever paid a dividend?
No, Telomir Pharmaceuticals has no a history of paying dividends to its shareholders. Telomir Pharmaceuticals is not known for its dividend payments.
Why doesn't Telomir Pharmaceuticals pay dividends?
There are several potential reasons why Telomir Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Telomir Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Telomir Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Telomir Pharmaceuticals a dividend aristocrat?
Telomir Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Telomir Pharmaceuticals a dividend king?
Telomir Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Telomir Pharmaceuticals a dividend stock?
No, Telomir Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Telomir Pharmaceuticals stocks?
To buy Telomir Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Telomir Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.